ADAP Advocacy has published two new infographics as part of its 340B Project, focusing on medical debt and its impact on patients. These visual resources complement the organization's recently released commercial materials and form part of the ongoing national advocacy campaign questioning whether the 340B Drug Pricing Program has become "too big to fail."
The first infographic, titled "340B Too Big to Fail – Medical Debt – Part 1," examines the original purpose of the 340B Drug Pricing Program, which was designed to help low-income patients access healthcare services. Despite the program's growth to $66 billion in scale, primarily benefiting hospitals, medical debt remains a significant financial burden for many Americans. The infographic highlights that most of this debt is owed to hospitals eligible for the 340B program, raising questions about whether the program's benefits are reaching intended patients.
The second infographic, "340B Too Big to Fail – Medical Debt – Part 2," reveals how many hospitals participating in the 340B Program engage in aggressive, predatory debt collection practices that often damage consumer credit reports. According to the findings, these hospitals frequently choose not to set reasonable prices or offer robust financial assistance programs. Instead, they pursue legal action against patients rather than providing free charity care as required by law.
The two-part infographic series is available for download at https://www.adapadvocacy.org/publications.html#i. These resources provide visual data and analysis that could influence policy discussions around healthcare affordability and program accountability.
The release of these infographics has significant implications for healthcare policy, patient advocacy, and hospital practices. For patients, the findings highlight ongoing challenges in accessing affordable care despite federal programs designed to assist them. For the healthcare industry, the infographics may prompt increased scrutiny of how 340B program savings are utilized and whether hospitals are fulfilling their charity care obligations. For policymakers, the data could inform future reforms to ensure that the 340B program better serves its intended purpose of helping vulnerable patients access necessary medications and treatments without facing financial ruin.
